Analysts expect Palvella Therapeutics, Inc. to report revenue of 2.16 M for Q2 24, against a range of 1.96 M to 2.36 M. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q2 24 | Q3 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | |||||||||||
| High Estimate | 2.36 M | 1.15 M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.24 M | 3.48 M | 23.59 M | |||||||||||
| Low Estimate | 1.96 M | 1.04 M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.90 M | 2.88 M | 19.81 M | |||||||||||
| Consensus Estimate | 2.16 M | 1.10 M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.07 M | 3.18 M | 21.70 M |
Analysts expect Palvella Therapeutics, Inc. to report earnings per share of -2.49 for Q2 24, against a range of -2.62 to -2.36. The most recent reported quarter, Q2 26, came in at -1.52, a 33.3% miss against the -1.14 consensus.
| Metric | Q2 24 | Q3 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | - | -1.18 | -0.74 | -0.86 | -1.03 | -1.08 | -1.20 | -1.52 | - | - | - | - | - | - | - | |||||||||||
| High Estimate | -2.36 | -3.86 | -1.12 | -0.74 | -0.78 | -0.91 | -0.94 | -1.07 | -1.68 | -1.87 | -2.12 | -2.59 | -2.01 | -2.48 | -1.73 | |||||||||||
| Low Estimate | -2.62 | -4.68 | -1.24 | -0.80 | -0.86 | -1.03 | -1.06 | -1.21 | -1.88 | -2.21 | -2.44 | -3.03 | -2.29 | -2.66 | -1.97 | |||||||||||
| Consensus Estimate | -2.49 | -4.27 | -1.18 | -0.77 | -0.82 | -0.97 | -1.00 | -1.14 | -1.78 | -2.04 | -2.28 | -2.81 | -2.15 | -2.57 | -1.85 |
Pull Wall Street consensus for Palvella Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=PVLA&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "PVLA", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=PVLA&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();